Correlation Engine 2.0
Clear Search sequence regions
Bookmark Forward

QuickView for Isosorbide Mononitrate (compound)

Name: isosorbide-5-mononitrate
PubChem Compound ID: 27661
Molecular formula: C6H9NO6
Molecular weight: 191.139 g/mol
Isosorbide 5-nitrate; Fem-Mono; IHD; Ismo (TN); Elantan; Imdur; Corangin; ISMN Stada; 5-Ismn; Monocord 20.
show more »
Name: isosorbide-5-mononitrate
Name (isomeric): DB01020
Drug Type: small molecule
Monosorbitrate; IHD; Isosorbidi Mononitras [Latin]; ISMN; Mononitrate d'Isosorbide [French]; Mononitrato de Isosorbida [Spanish]
Brand: Edistol, Monoclair, Elantan Retard, Olicard, Monocord 20, Sigacora, Duride, Ismox, Monicor, Monoket Retard, Ismexin, Monisid, Pentacard, Monolong 60, IS 5MN, Conpin, Elantan, Isomon, Ismn Abz, Monizid, Nitex, Mononit 40, Ismn Basics, Monit 20, Monotrate, Mono-Mack, Isopen-20, Nitramin, Vasdilat, Mononit Retard 50, Conpin Retardkaps, Etimonis, Ismn Heumann, Medocor, Iturol, Pentacard 20, Ismn Hexal, Ismo-20, Epicordin, Corangin Sr, Mono Corax Retard, Imodur, Uniket, Isomonit, Plodin, Isomonat, Olicardin, Multitab, Monodur Durules, Imdur 60, Pertil, Monopront, Orasorbil, Imazin, Monocord 40, ISMN AL, Mono-Sanorania, Ismn Stada, Promocard, Turimonit, Ismn Apogepha, Monis, Monit, Monolong 40, Ismn Atid, Imtrate, Monoket, Imdur, Monosordil, Mononit 20, Monosorb, Elantan Long, Sorbimon, Monocedocard, Mono Corax, Imdur Durules, Mono Mack, Monocord 50 Sr, Monoket Od, Ismn Lannacher, Vasotrate, Monolong, Corangin, Fem-Mono, Ismo, Monosigma, Mononit, Percorina, Titarane
Category: Nitrates and Nitrites, Vasodilator Agents, Nitric Oxide Donors
CAS number: 16051-77-7
Indication: For the prevention of angina pectoris due to coronary artery disease and the treatment of acute and chronic angina pectoris, hypertension, and myocardial infarction.
Pharmacology: Isosorbide-5-mononitrate, the long-acting metabolite of isosorbide dinitrate, is used as a vasodilatory agent in the management of angina pectoris. By dilating the vessels, it lowers the blood pressure and reduces the left ventricular preload and afterload, therefore, leads to a reduction of myocardial oxygen requirement.
Mechanism of Action:
Similar to other nitrites and organic nitrates, Isosorbide Mononitrate is converted to nitric oxide (NO), an active intermediate compound which activates the enzyme guanylate cyclase (Atrial natriuretic peptide receptor A). This stimulates the synthesis of cyclic guanosine 3',5'-monophosphate (cGMP) which then activates a series of protein kinase-d...
show more »
Absorption: 100%
Protein binding: 5%
Biotransformation: Hepatic
Route of elimination: Isosorbide mononitrate is primarily metabolized by the liver, but unlike oral isosorbide dinitrate, it is not subject to first-pass metabolism. Isosorbide mononitrate is cleared by denitration to isosorbide and glucuronidation as the mononitrate, with 96% of the administered dose excreted in the urine within 5 days and only about 1% eliminated in the feces. At least six different compounds have been detected in urine, with about 2% of the dose excreted as the unchanged drug and at least five metabolites.
Half Life: 5 hours
Clearance: 120–122 mL/min [Single dose of 60 mg PO] 151–187 mL/min [Single dose of extended-release tablet 60 mg PO] 132-151 mL/min [Multiple doses of extended release tablet 60 mg PO] 119-140 mL/min [Multiple doses of extended release tablet 120 mg PO]
Toxicity: Symptoms of overdose include vasodilatation, venous pooling, reduced cardiac output, and hypotension. There are no data suggesting what dose of isosorbide mononitrate is likely to be life-threatening in humans. In rats and mice, there is significant lethality at doses of 2000 mg/kg and 3000 mg/kg, respectively.
Affected organisms: Humans and other mammals
Food interaction:
Take without regard to meals.
Drug interaction:
TelithromycinTelithromycin may reduce clearance of Isosorbide Mononitrate. Consider alternate therapy or monitor for changes in the therapeutic/adverse effects of Isosorbide Mononitrate if Telithromycin is initiated, discontinued or dose changed.
VoriconazoleVoriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of isosorbide mononitrate by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of isosorbide mononitrate if voriconazole is initiated, discontinued or dose changed.
TadalafilThe vasodilatory effects of Isosobide mononitrate may be increased by Tadalafil. Severe hypotension may occur. Concomitant therapy is contraindicated.
SildenafilPossible significant hypotension with this combination
UdenafilThe vasodilatory effects of Isosobide mononitrate may be increased by Udenafil. Severe hypotension may occur. Concomitant therapy is contraindicated.
show more »